Method of providing disease-specific binding molecules and targets

Details for Australian Patent Application No. 2008203703 (hide)

Owner University of Zurich

Inventors Esslinger, Christoph; Knobloch, Marlen; Tissot, Kathrin; Grimm, Jan; Hock, Christoph; Nitsch, Roger

Agent Cullen & Co

Pub. Number AU-A-2008203703

PCT Pub. Number WO2008/081008

Priority 60/934,291 11.06.07 US; 60/878,831 05.01.07 US; 07020341.9 17.10.07 EP; 07000211.8 05.01.07 EP

Filing date 7 January 2008

Wipo publication date 10 July 2008

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/081008 Priority application(s): WO2008/081008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008203707-Spiropiperidine derivatives as NK3 antagonists

2008203687-Installation for enhanced oil recovery using water-soluble polymers, method implementing same